As I recall there was something that came out about Apabetalone having a possible positive impact on degenerative retinas or something like that.

https://www.prnewswire.com/news-releases/resverlogix-highlights-unique-properties-of-apabetalone-in-both-a-rare-muscular-dystrophy-fshd-and-neurodegenerative-eye-disease-613571843.html

The first indication was published in the Journal of Neuroinflammation which described the inhibition of bromodomain and extra-terminal (BET) epigenetic readers, including apabetalone (RVX-208), as having therapeutic potential in degenerative diseases of the eye (retinal).